Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) shot up 4.9% on Tuesday . The stock traded as high as $0.37 and last traded at $0.37. 249 shares were traded during mid-day trading, a decline of 85% from the average session volume of 1,705 shares. The stock had previously closed at $0.35.
Zelira Therapeutics Trading Up 4.9 %
The firm’s 50-day moving average price is $0.44 and its 200 day moving average price is $0.43.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Read More
- Five stocks we like better than Zelira Therapeutics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Pros And Cons Of Monthly Dividend Stocks
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
